Jingyou Yu

11.7k total citations · 1 hit paper
49 papers, 1.4k citations indexed

About

Jingyou Yu is a scholar working on Infectious Diseases, Immunology and Virology. According to data from OpenAlex, Jingyou Yu has authored 49 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 22 papers in Immunology and 9 papers in Virology. Recurrent topics in Jingyou Yu's work include SARS-CoV-2 and COVID-19 Research (17 papers), interferon and immune responses (10 papers) and HIV Research and Treatment (9 papers). Jingyou Yu is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (17 papers), interferon and immune responses (10 papers) and HIV Research and Treatment (9 papers). Jingyou Yu collaborates with scholars based in United States, China and Canada. Jingyou Yu's co-authors include Shan‐Lu Liu, Dan H. Barouch, Catherine Jacob-Dolan, Katherine McMahan, Daniel Sellers, Jinyan Liu, Gabriel Dagotto, Ai‐ris Y. Collier, Abishek Chandrashekar and Julia Barrett and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Jingyou Yu

46 papers receiving 1.3k citations

Hit Papers

Vaccines elicit highly conserved cellular immunity to SAR... 2022 2026 2023 2024 2022 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingyou Yu United States 20 823 451 276 209 165 49 1.4k
Camila H. Coelho United States 11 784 1.0× 348 0.8× 315 1.1× 120 0.6× 84 0.5× 32 1.2k
Shan Su China 19 570 0.7× 320 0.7× 279 1.0× 250 1.2× 172 1.0× 45 1.1k
Delphine Planas Canada 15 805 1.0× 389 0.9× 253 0.9× 130 0.6× 344 2.1× 35 1.3k
Naoko Iwata‐Yoshikawa Japan 18 1.6k 1.9× 297 0.7× 329 1.2× 385 1.8× 88 0.5× 36 2.0k
Yonggang Li China 18 361 0.4× 357 0.8× 235 0.9× 267 1.3× 79 0.5× 63 1.1k
Megan Steain Australia 23 399 0.5× 518 1.1× 391 1.4× 688 3.3× 181 1.1× 54 1.6k
Hiroshi Katoh Japan 15 1.3k 1.6× 212 0.5× 440 1.6× 332 1.6× 68 0.4× 38 1.9k
Peggy Möller Germany 13 984 1.2× 279 0.6× 237 0.9× 395 1.9× 76 0.5× 15 1.3k
Priya Luthra United States 22 986 1.2× 541 1.2× 429 1.6× 562 2.7× 62 0.4× 29 1.7k
Bobo Wing-Yee Mok Hong Kong 22 697 0.8× 346 0.8× 451 1.6× 425 2.0× 45 0.3× 34 1.5k

Countries citing papers authored by Jingyou Yu

Since Specialization
Citations

This map shows the geographic impact of Jingyou Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingyou Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingyou Yu more than expected).

Fields of papers citing papers by Jingyou Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingyou Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingyou Yu. The network helps show where Jingyou Yu may publish in the future.

Co-authorship network of co-authors of Jingyou Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jingyou Yu. A scholar is included among the top collaborators of Jingyou Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingyou Yu. Jingyou Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xuyuan, et al.. (2025). Unlocking the potential of circular RNA vaccines: a bioinformatics and computational biology perspective. EBioMedicine. 114. 105638–105638. 5 indexed citations
2.
Zhang, Yao, Shixiong Li, & Jingyou Yu. (2025). Protocol for evaluating humoral immune responses in mice following SARS-CoV-2 vaccination. STAR Protocols. 6(1). 103548–103548.
3.
Zhang, Weihao, Qi Cheng, Jussi Hepojoki, et al.. (2024). SARS-CoV-2 NSP16 promotes IL-6 production by regulating the stabilization of HIF-1α. Cellular Signalling. 124. 111387–111387. 2 indexed citations
4.
Girnius, Nomeda, Benjamin Marks, Jingyou Yu, et al.. (2024). Cilengitide sensitivity is predicted by overall integrin expression in breast cancer. Breast Cancer Research. 26(1). 187–187. 2 indexed citations
5.
Zhao, Dongyu, et al.. (2024). Optimising vaccine immunogenicity in ageing populations: key strategies. The Lancet Infectious Diseases. 25(1). e23–e33. 8 indexed citations
6.
Li, Shixiong, Yao Zhang, Dongfang Wang, et al.. (2023). Early Emerging SARS-CoV-2 Spike Mutants Are Diversified in Virologic Properties but Elicit Compromised Antibody Responses. Viruses. 15(12). 2401–2401. 1 indexed citations
7.
Vidal, Samuel J., Daniel Sellers, Jingyou Yu, et al.. (2023). Attenuated Mycobacterium tuberculosis vaccine protection in a low-dose murine challenge model. iScience. 26(6). 106963–106963. 7 indexed citations
8.
Collier, Ai‐ris Y., Catherine Brown, Katherine McMahan, et al.. (2022). Characterization of immune responses in fully vaccinated individuals after breakthrough infection with the SARS-CoV-2 delta variant. Science Translational Medicine. 14(641). eabn6150–eabn6150. 43 indexed citations
9.
Cooper, Amanda, Abishek Chandrashekar, Krishnendu Chakraborty, et al.. (2022). A genetically engineered, stem-cell-derived cellular vaccine. Cell Reports Medicine. 3(12). 100843–100843. 1 indexed citations
10.
Gebre, Makda S., Susanne Rauch, Nicole Roth, et al.. (2022). mRNA vaccines induce rapid antibody responses in mice. npj Vaccines. 7(1). 88–88. 14 indexed citations
11.
Zohar, Tomer, Carolin Loos, Stephanie Fischinger, et al.. (2020). Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality. Cell. 183(6). 1508–1519.e12. 153 indexed citations
13.
Martinot, Amanda J., Eryn Blass, Jingyou Yu, et al.. (2020). Protective efficacy of an attenuated Mtb ΔLprG vaccine in mice. PLoS Pathogens. 16(12). e1009096–e1009096. 14 indexed citations
14.
Dagotto, Gabriel, Jingyou Yu, & Dan H. Barouch. (2020). Approaches and Challenges in SARS-CoV-2 Vaccine Development. Cell Host & Microbe. 28(3). 364–370. 70 indexed citations
15.
Lu, Wuxun, Shuliang Chen, Jingyou Yu, et al.. (2019). The Polar Region of the HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing the gp120-gp41 Association. Journal of Virology. 93(7). 10 indexed citations
16.
Li, Anzhong, Jingyou Yu, Mijia Lu, et al.. (2018). A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein. Nature Communications. 9(1). 3067–3067. 60 indexed citations
17.
Miller, A. Dusty, M. De las Heras, Jingyou Yu, et al.. (2017). Evidence against a role for jaagsiekte sheep retrovirus in human lung cancer. Retrovirology. 14(1). 3–3. 6 indexed citations
18.
Yu, Jingyou, et al.. (2013). Enhanced delivery of human growth hormone across cell membrane by Tat-PTD. Endocrine. 46(1). 138–147. 3 indexed citations
19.
Chen, Dandan, et al.. (2012). PcLT, a novel C-type lectin from Procambarus clarkii, is involved in the innate defense against Vibrio alginolyticus and WSSV. Developmental & Comparative Immunology. 39(3). 255–264. 51 indexed citations
20.
Maor, Yehoshua, Jingyou Yu, Paula M. Kuzontkoski, et al.. (2012). Cannabidiol Inhibits Growth and Induces Programmed Cell Death in Kaposi Sarcoma-Associated Herpesvirus-Infected Endothelium. Genes & Cancer. 3(7-8). 512–520. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026